Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

China takes hyperthermia system for cancer treatment

BSD Medical : 22 October, 2013  (Application Story)
The BSD-2000 hyperthermia system will be used in China for the non-invasive therapeutic heat treatment of deeply located tumours
China takes hyperthermia system for cancer treatment


BSD Medical Corporation has announced the sale and shipment of a BSD-2000 hyperthermia system (BSD-2000) to Dalian Orientech, the Company’s exclusive distributor in the People’s Republic of China. Orientech has placed a significant number of BSD-2000 Hyperthermia Systems in leading hospitals throughout China. The BSD-2000 non-invasively delivers localized therapeutic heating (hyperthermia) by applying radiofrequency (RF) energy to certain cancerous tumours, including those located deep within the body. Clinical studies have shown that hyperthermia treatment can kill cancer cells directly, as well as increase the effectiveness of other cancer therapies, including radiation therapy, for the treatment of certain tumours.



BSD signed a long-term exclusive distributor agreement with Orientech in 2005. During the period of the original agreement BSD sold 17 BSD-2000s to Orientech. In 2012 BSD renewed its exclusive distributorship agreement with Orientech. The 2012 agreement requires Orientech to purchase a minimum of 32 BSD-2000s over a four-year period, commencing when Orientech receives renewal of their original approval to sell the BSD-2000 from China’s Food and Drug Administration (CFDA). CFDA approval has to be renewed every four years for all medical devices. While renewal from the CFDA is pending, Orientech has obtained approval to import BSD-2000s on a limited basis.


Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo